High Use of SABAs is Associated with Higher Exacerbation Rate in Dutch Patients with Asthma

Purpose: Many patients with asthma still have insufficient disease control, despite the availability of effective treatment options. A substantial proportion of patients appear to rely more on short-acting beta2-agonist (SABA) rather than on anti-inflammatory maintenance treatment. The aim of this study was to describe differences in indicators of asthma symptoms and exacerbations among patients using more or less SABA than the guideline-recommended threshold of <3 times/week. Patients and Methods: Data from Dutch respondents in the European REcognise Asthma and LInk to Symptoms and Experie... Mehr ...